Home Featured Page 168

Featured

Latest

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

Dylan Beynon – Mindbloom – At Home Ketamine

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the...

Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic...

PT299 – Ed Prideaux – HPPD (Hallucinogen Persisting Perception Disorder): A...

Psychedelic Bulletin: The Cost-Effectiveness of MDMA for PTSD; The Challenges Ahead...

Psychedelic Research Bulletin: February 2022

PT298 – Michael Sapiro, PsyD – Vital Psychedelic Conversations

The Need for an International Psychedelic Religious Survey

Numinus Wellness Announces Voting Results From its Annual General and Special...

MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program

1...167168169...292 Page 168 of 292

EDITOR PICKS

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

Dylan Beynon – Mindbloom – At Home Ketamine

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the...

Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic...

PT299 – Ed Prideaux – HPPD (Hallucinogen Persisting Perception Disorder): A...

Psychedelic Bulletin: The Cost-Effectiveness of MDMA for PTSD; The Challenges Ahead...

Psychedelic Research Bulletin: February 2022

PT298 – Michael Sapiro, PsyD – Vital Psychedelic Conversations

The Need for an International Psychedelic Religious Survey

Numinus Wellness Announces Voting Results From its Annual General and Special...

MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program

EDITOR PICKS

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY